Cyclcic FR-900520 microbial biotransformation agent

Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435118, 435899, C12P 1716, C12R 156

Patent

active

052216250

ABSTRACT:
Described is a process for producing a new immunosuppressant, a C-19/C-22 cyclic hemiketal (Compound I) biotransformation analog of FR-900520, under novel fermentation conditions utilizing the novel microorganism, Streptomyces sp. (Merck Culture Collection MA6963) ATCC No. 55230. The macrolide immunosuppressant is useful in preventing human host rejection of foreign organ transplants, e.g. bone marrow, liver, lung, kidney and heart transplants.

REFERENCES:
patent: 3244592 (1966-04-01), Arai
patent: 4081531 (1978-03-01), Arai et al.
patent: 4242453 (1980-12-01), Umezawa et al.
patent: 4264607 (1981-04-01), Dewey et al.
patent: 4894344 (1990-01-01), Sugiyama et al.
"Catalogue of Bacteria and Phage" 17th ed. ATCC Ed. Gherna et al. 1989 p. 228 S. lavendulae.
J. Antibiotics A15, pp. 231-232, by Arai Jul. 31, 1962.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cyclcic FR-900520 microbial biotransformation agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclcic FR-900520 microbial biotransformation agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclcic FR-900520 microbial biotransformation agent will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1440680

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.